Proteolytic processing of tau

Biochemical Society Transactions

Volumn 38, Issue 4, 2010, Pages 955-961

  Wang, Yipeng ^a   Garg, Sarika ^a   Mandelkow, Eva Maria ^a   Mandelkow, Eckhard ^a  

^a MAX PLANCK UNIT FOR STRUCTURAL MOLECULAR BIOLOGY   (Germany)

Author keywords

Aggregation; Alzheimer's disease; Fragmentation; Proteolysis; Tau; Tauopathy

Indexed keywords

AMINOPEPTIDASE; CALPAIN; CASPASE; CATHEPSIN; PROTEASOME; PUROMYCIN; TAU PROTEIN; THROMBIN;

PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; TAUOPATHY;

ANIMALS; CELLS, CULTURED; CHEMICAL PRECIPITATION; HUMANS; MODELS, BIOLOGICAL; PEPTIDE HYDROLASES; PROTEIN MULTIMERIZATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; TAU PROTEINS;

EID: 77955972018     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0380955     Document Type: Review

References (79)

1. Ballatore, C., Lee, V.M. and Trojanowski, J.Q. (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 8, 663-672
2. Schneider, A. and Mandelkow, E. (2008) Tau-based treatment strategies in neurodegenerative diseases. Neurotherapeutics 5, 443-457
3. Chen, F., David, D., Ferrari, A. and Gotz, J. (2004) Posttranslational modifications of tau: role in human tauopathies and modeling in transgenic animals. Curr. Drug Targets 5, 503-515
4. Lee, V.M., Goedert, M. and Trojanowski, J.Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159
5. Goedert, M. and Spillantini, M.G. (2001) Tau gene mutations and neurodegeneration. Biochem. Soc. Symp. 67, 59-71
6. Johnson, G.V. (2006) Tau phosphorylation and proteolysis: insights and perspectives. J. Alzheimer's Dis. 9, 243-250
7. Khlistunova, I., Biernat, J., Wang, Y., Pickhardt, M., von Bergen, M., Gazova, Z., Mandelkow, E. and Mandelkow, E.M. (2006) Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs. J. Biol. Chem. 281, 1205-1214
8. Wang, Y.P., Biernat, J., Pickhardt, M., Mandelkow, E. and Mandelkow, E.M. (2007) Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model. Proc. Natl. Acad. Sci. U.S.A. 104, 10252-10257
9. von Bergen, M., Barghorn, S., Muller, S.A., Pickhardt, M., Biernat, J., Mandelkow, E.M., Davies, P., Aebi, U. and Mandelkow, E. (2006) The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis. Biochemistry 45, 6446-6457
10. 2+-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles. EMBO J. 9, 3539-3544
11. Wischik, C.M., Novak, M., Edwards, P.C., Klug, A., Tichelaar, W. and Crowther, R.A. (1988) Structural characterization of the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 85, 4884-4888
12. Jakes, R., Novak, M., Davison, M. and Wischik, C.M. (1991) Identification of 3- and 4-repeat tau isoforms within the PHF in Alzheimer's disease. EMBO J. 10, 2725-2729
13. Shi, Y. (2002) Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 9, 459-470
14. Nicholson, D.W. (1999) Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6, 1028-1042
15. Cohen, G.M. (1997) Caspases: the executioners of apoptosis. Biochem. J. 326, 1-16
16. 15a Horowitz, P.M., La Pointe, N., Guillozet-Bongaarts, A.L., Berry, R.W. and Binder, L.I. (2006) N-terminal fragments of tau inhibit full-length tau polymerization in vitro. Biochemistry 45, 12859-12866
17. Gamblin, T.C., Chen, F., Zambrano, A., Abraha, A., Lagalwar, S., Guillozet, A.L., Lu, M., Fu, Y., Garcia-Sierra, F., LaPointe, N. et al. (2003) Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 100, 10032-10037
18. Rissman, R.A., Poon, W.W., Blurton-Jones, M., Oddo, S., Torp, R., Vitek, M.P., LaFerla, F.M., Rohn, T.T. and Cotman, C.W. (2004) Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J. Clin. Invest. 114, 121-130
19. Horowitz, P.M., Patterson, K.R., Guillozet-Bongaarts, A.L., Reynolds, M.R., Carroll, C.A., Weintraub, S.T., Bennett, D.A., Cryns, V.L., Berry, R.W. and Binder, L.I. (2004) Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease. J. Neurosci. 24, 7895-7902
20. 18a Basurto-Islas, G., Luna-Munoz, J., Guillozet-Bongaarts, A.L., Binder, L.I., Mena, R. and Garcia-Siera, F. (2008) Accumulation of aspatic acid 421- and glutamic acid 391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease. J. Neuropathol. Exp. Neurol. 67, 470-483
21. Guo, H., Albrecht, S., Bourdeau, M., Petzke, T., Bergeron, C. and LeBlanc, A.C. (2004) Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease. Am. J. Pathol. 165, 523-531
22. Rohn, T.T., Rissman, R.A., Davis, M.C., Kim, Y.E., Cotman, C.W. and Head, E. (2002) Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Neurobiol. Dis. 11, 341-354
23. 20a Corsetti, V. Anadoro, G., Gentile, A., Capsoni, S., Ciotti, M.T., Cencioni, M.T., Atlanta, A., Canu, N. Rohn, T.T., Cattaneo, A. and Calissano, P. (2008) Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimers disease models. Mol. Cell. Neurosci. 38, 381-392
24. Cho, J.H. and Johnson, G.V. (2004) Glycogen synthase kinase 3β induces caspase-cleaved tau aggregation in situ. J. Biol. Chem. 279, 54716-54723
25. Guillozet-Bongaarts, A.L., Cahill, M.E., Cryns, V.L., Reynolds, M.R., Berry, R.W. and Binder, L.I. (2006) Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo. J. Neurochem. 97, 1005-1014
26. Fasulo, L., Ugolini, G. and Cattaneo, A. (2005) Apoptotic effect of caspase-3 cleaved tau in hippocampal neurons and its potentiation by tau FTDP-mutation N279K. J. Alzheimer's Dis. 7, 3-13
27. Quintanilla, R.A., Matthews-Roberson, T.A., Dolan, P.J. and Johnson, G.V. (2009) Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease. J. Biol. Chem. 284, 18754-18766
28. Spires-Jones, T.L., de Calignon, A., Matsui, T., Zehr, C., Pitstick, R., Wu, H.Y., Osetek, J.D., Jones, P.B., Bacskai, B.J., Feany, M.B. et al. (2008) In vivo imaging reveals dissociation between caspase activation and acute neuronal death in tangle-bearing neurons. J. Neurosci. 28, 862-867
29. Spires-Jones, T.L., Stoothoff, W.H., de Calignon, A., Jones, P.B. and Hyman, B.T. (2009) Tau pathophysiology in neurodegeneration: a tangled issue. Trends Neurosci. 32, 150-159
30. de Calignon, A., Fox, L.M., Pitstick, R., Carlson, G.A., Bacskai, B.J., Spires-Jones, T.L. and Hyman, B.T. (2010) Caspase activation precedes and leads to tangles. Nature 464, 1201-1204
31. Zhang, Y., Goodyer, C. and LeBlanc, A. (2000) Selective and protracted apoptosis in human primary neurons microinjected with active caspase-3, -6, -7, and -8. J. Neurosci. 20, 8384-8389
32. Goll, D.E., Thompson, V.F., Taylor, R.G. and Zalewska, T. (1992) Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin? BioEssays 14, 549-556
33. Sasaki, T., Kikuchi, T., Yumoto, N., Yoshimura, N. and Murachi, T. (1984) Comparative specificity and kinetic studies on porcine calpain I and calpain II with naturally occurring peptides and synthetic fluorogenic substrates. J. Biol. Chem. 259, 12489-12494
34. Tompa, P., Buzder-Lantos, P., Tantos, A., Farkas, A., Szilagyi, A., Banoczi, Z., Hudecz, F. and Friedrich, P. (2004) On the sequential determinants of calpain cleavage. J. Biol. Chem. 279, 20775-20785
35. Cuerrier, D., Moldoveanu, T. and Davies, P.L. (2005) Determination of peptide substrate specificity for μ-calpain by a peptide library-based approach: the importance of primed side interactions. J. Biol. Chem. 280, 40632-40641
36. Rao, M.V., Mohan, P.S., Peterhoff, C.M., Yang, D.S., Schmidt, S.D., Stavrides, P.H., Campbell, J., Chen, Y., Jiang, Y., Paskevich, P.A. et al. (2008) Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST overexpression. J. Neurosci. 28, 12241-12254
37. Saito, K., Elce, J.S., Hamos, J.E. and Nixon, R.A. (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. U.S.A. 90, 2628-2632
38. Johnson, G.V., Jope, R.S. and Binder, L.I. (1989) Proteolysis of tau by calpain. Biochem. Biophys. Res. Commun. 163, 1505-1511
39. Litersky, J.M., Scott, C.W. and Johnson, G.V. (1993) Phosphorylation, calpain proteolysis and tubulin binding of recombinant human tau isoforms. Brain Res. 604, 32-40
40. Yang, L.S., Gordon-Krajcer, W. and Ksiezak-Reding, H. (1997) Tau released from paired helical filaments with formic acid or guanidine is susceptible to calpain-mediated proteolysis. J. Neurochem. 69, 1548-1558
41. Canu, N., Dus, L., Barbato, C., Ciotti, M.T., Brancolini, C., Rinaldi, A.M., Novak, M., Cattaneo, A., Bradbury, A. and Calissano, P. (1998) Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J. Neurosci. 18, 7061-7074
42. Roberson, E.D., Scearce-Levie, K., Palop, J.J., Yan, F., Cheng, I.H., Wu, T., Gerstein, H., Yu, G.Q. and Mucke, L. (2007) Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model. Science 316, 750-754
43. Park, S.Y. and Ferreira, A. (2005) The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates β-amyloid-induced neurodegeneration. J. Neurosci. 25, 5365-5375
44. King, M.E., Kan, H.M., Baas, P.W., Erisir, A., Glabe, C.G. and Bloom, G.S. (2006) Tau-dependent microtubule disassembly initiated by prefibrillar β-amyloid. J. Cell Biol. 175, 541-546
45. Fenton, 2nd, J.W. (1986) Thrombin. Ann. N.Y. Acad. Sci. 485, 5-15
46. Akiyama, H., Ikeda, K., Kondo, H. and McGeer, P.L. (1992) Thrombin accumulation in brains of patients with Alzheimer's disease. Neurosci. Lett. 146, 152-154
47. Arai, T., Miklossy, J., Klegeris, A., Guo, J.P. and McGeer, P.L. (2006) Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brain. J. Neuropathol. Exp. Neurol. 65, 19-25
48. Arai, T., Guo, J.P. and McGeer, P.L. (2005) Proteolysis of non-phosphorylated and phosphorylated tau by thrombin. J. Biol. Chem. 280, 5145-5153
49. Dihanich, M., Kaser, M., Reinhard, E., Cunningham, D. and Monard, D. (1991) Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6, 575-581
50. Yang, A.J., Chandswangbhuvana, D., Margol, L. and Glabe, C.G. (1998) Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Aβ1-42 pathogenesis. J. Neurosci. Res. 52, 691-698
51. Cataldo, A.M., Thayer, C.Y., Bird, E.D., Wheelock, T.R. and Nixon, R.A. (1990) Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin. Brain Res. 513, 181-192
52. Bednarski, E. and Lynch, G. (1996) Cytosolic proteolysis of tau by cathepsin D in hippocampus following suppression of cathepsins B and L. J. Neurochem. 67, 1846-1855
53. Kenessey, A., Nacharaju, P., Ko, L.W. and Yen, S.H. (1997) Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration. J. Neurochem. 69, 2026-2038
54. Wang, Y., Martinez-Vicente, M., Kruger, U., Kaushik, S., Wong, E., Mandelkow, E.M., Cuervo, A.M. and Mandelkow, E. (2009) Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Hum. Mol. Genet. 18, 4153-4170
55. Anderson, A.J., Stoltzner, S., Lai, F., Su, J. and Nixon, R.A. (2000) Morphological and biochemical assessment of DNA damage and apoptosis in Down syndrome and Alzheimer disease, and effect of postmortem tissue archival on TUNEL. Neurobiol. Aging 21, 511-524
56. Rawlings, N.D. and Barrett, A.J. (1993) Evolutionary families of peptidases. Biochem. J. 290, 205-218
57. Tobler, A.R., Constam, D.B., Schmitt-Graff, A., Malipiero, U., Schlapbach, R. and Fontana, A. (1997) Cloning of the human puromycin-sensitive aminopeptidase and evidence for expression in neurons. J. Neurochem. 68, 889-897
58. McLellan, S., Dyer, S.H., Rodriguez, G. and Hersh, L.B. (1988) Studies on the tissue distribution of the puromycin-sensitive enkephalin-degrading aminopeptidases. J. Neurochem. 51, 1552-1559
59. Karsten, S.L., Sang, T.K., Gehman, L.T., Chatterjee, S., Liu, J., Lawless, G.M., Sengupta, S., Berry, R.W., Pomakian, J., Oh, H.S. et al. (2006) A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration. Neuron 51, 549-560
60. Sengupta, S., Horowitz, P.M., Karsten, S.L., Jackson, G.R., Geschwind, D.H., Fu, Y., Berry, R.W. and Binder, L.I. (2006) Degradation of tau protein by puromycin-sensitive aminopeptidase in vitro. Biochemistry 45, 15111-15119
61. Kisselev, A.F., Akopian, T.N. and Goldberg, A.L. (1998) Range of sizes of peptide products generated during degradation of different proteins by archaeal proteasomes. J. Biol. Chem. 273, 1982-1989
62. Kisselev, A.F., Akopian, T.N., Woo, K.M. and Goldberg, A.L. (1999) The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes: implications for understanding the degradative mechanism and antigen presentation. J. Biol. Chem. 274, 3363-3371
63. Benaroudj, N., Tarcsa, E., Cascio, P. and Goldberg, A.L. (2001) The unfolding of substrates and ubiquitin-independent protein degradation by proteasomes. Biochimie 83, 311-318
64. Tofaris, G.K., Layfield, R. and Spillantini, M.G. (2001) α-Synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome. FEBS Lett. 509, 22-26
65. WAF1/CIP1 is a binding site for the C8 α-subunit of the 20S proteasome. EMBO J. 20, 2367-2375
66. Ciechanover, A. (2001) Linking ubiquitin, parkin and synphilin-1. Nat. Med. 7, 1108-1109
67. David, D.C., Layfield, R., Serpell, L., Narain, Y., Goedert, M. and Spillantini, M.G. (2002) Proteasomal degradation of tau protein. J. Neurochem. 83, 176-185
68. Keller, J.N., Hanni, K.B. and Markesbery, W.R. (2000) Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75, 436-439
69. Lopez Salon, M., Morelli, L., Castano, E.M., Soto, E.F. and Pasquini, J.M. (2000) Defective ubiquitination of cerebral proteins in Alzheimer's disease. J. Neurosci. Res. 62, 302-310
70. Keck, S., Nitsch, R., Grune, T. and Ullrich, O. (2003) Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. J. Neurochem. 85, 115-122
71. Bornstein, P. and Balian, G. (1977) Cleavage at Asn-Gly bonds with hydroxylamine. Methods Enzymol. 47, 132-145
72. Watanabe, A., Hong, W.K., Dohmae, N., Takio, K., Morishima-Kawashima, M. and Ihara, Y. (2004) Molecular aging of tau: disulfide-independent aggregation and non-enzymatic degradation in vitro and in vivo. J. Neurochem. 90, 1302-1311
73. Geiger, T. and Clarke, S. (1987) Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides: succinimide-linked reactions that contribute to protein degradation. J. Biol. Chem. 262, 785-794
74. Johnson, G.V., Seubert, P., Cox, T.M., Motter, R., Brown, J.P. and Galasko, D. (1997) The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments. J. Neurochem. 68, 430-433
75. Portelius, E., Hansson, S.F., Tran, A.J., Zetterberg, H., Grognet, P., Vanmechelen, E., Hoglund, K., Brinkmalm, G., Westman-Brinkmalm, A., Nordhoff, E. et al. (2008) Characterization of tau in cerebrospinal fluid using mass spectrometry. J. Proteome Res. 7, 2114-2120
76. Wischik, C.M., Novak, M., Thogersen, H.C., Edwards, P.C., Runswick, M.J., Jakes, R., Walker, J.E., Milstein, C., Roth, M. and Klug, A. (1988) Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 85, 4506-4510
77. Novak, M., Kabat, J. and Wischik, C.M. (1993) Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J. 12, 365-370
78. Mena, R., Edwards, R.C., Harrington, C.R., Mukaetova- Ladinska, E.B. and Wischik, C.M. (1996) Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease. Acta Neuropathol. 91, 633-641
79. Wang, Y., Knïger, U., Mandelkow, E. and Mandelkow, E.M. (2010) Generation of tau aggregates and clearance by autophagy in an inducible cell model of tauopathy. Neurodegener. Dis. 7, 103-107